Leading the Way in Life Science Technologies

Attention Administrator - database is in test mode!

GEN Exclusives

More »

GEN Podcasts

The Sounds of Science podcast is brought to you by GEN. Listen as members of the editorial team—Editor-in-Chief John Sterling, Technical Editor Jeff Buguliskis, and Senior News Editor Alex Philippidis—showcase innovative research, new initiatives, and important policy by interviewing thought-leaders, eminent life-science researchers, and company leaders. These short, but informative podcasts will keep you up-to-date with the latest and most important life science advances.

August 2, 2007

INDIVIDUALIZED CANCER THERAPY

- GEN's Editor-in-Chief, John Sterling, interviews Dr. Robert Nagourney, Medical and Laboratory Director at Rational Therapeutics, about individualizing cancer therapies for patients.

July 26, 2007

NEXT GENERATION OF DNA AND RNA MICROARRAYS

- John Sterling, Editor-in-Chief of GEN, interviews Claude Gagne, Ph.D., Associate Professor of Life Sciences, New York Institute of Technology School of Health Professions, Behavioral, and Life Sciences

July 19, 2007

THE USE OF ANIMAL MODELS IN BIOLOGICAL RESEARCH

- GEN’s Editor-in-Chief, John Sterling, interviews Cheryl Marks, Ph.D., associate director of the division of cancer biology at the National Cancer Institute and program director of the Mouse Models of Human Cancers Consortium.

July 12, 2007

DERIVING BIOIDENTICAL HUMAN STEM CELLS FROM UNFERTILIZED EGGS

- GEN’s Editor-in-Chief John Sterling inteviews Jeffrey Janus, President, and Jeff Krstich, CEO, of International Stem Cell Corporation.

July 3, 2007

NON-VOLTAGE-GATED ION CHANNELS AS CNS DRUG TARGETS

- GEN's Editor-in-Chief John Sterling interviews Michael Cascio, Ph.D., Assistant Professor, Department of Molecular Genetics and Biochemistry, University of Pittsburgh

June 28, 2007

REAL TIME QUANTITATIVE PCR - RT-qPCR - IN A CLINICAL REFERENCE LABORATORY

- GEN's Editor-in-Chief, John Sterling, interviews Jeffery Stevenson, Ph.D., ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories

June 21, 2007

CANCER DRUG TARGET IDENTIFICATION AND VALIDATION

- GEN's Editor-in-Chief John Sterling interviews Sukru Tuzmen , Ph.D., Investigator, Head of Molecular Genetics Laboratory , Pharmaceutical Genomics Division, Translational Genomics Research Institute (TGEN)

June 14, 2007

microRNAs AND CANCER SUSCEPTIBILITY

- GEN's Editor-in-Chief John Sterling interviews Linda Siracusa, Ph.D., Associate Professor of Microbiology and Immunology at Jefferson Medical College of Thomas Jefferson University

June 7, 2007

DIRECTED EVOLUTION OF NON-BIOLOGICAL PROTEINS

- GEN's Editor-in-Chief interviews John C. Chaput, Ph.D., Principal Investigator, Center for Bio-Optical Nanotechnology, Biodesign Institute, Arizona State University.

May 31, 2007

PREPARING FOR PANDEMIC FLU

- GEN's Editor-in-Chief John Sterling interviews Dr. David Ozonoff from the Boston University School of Public Health

May 24, 2007

TRANSLATING PROTEOMICS AND BIOMARKER RESEARCH FINDINGS INTO THE CANCER CLINIC

- GEN's Editor-in-Chief John Sterling interviews Dr. Amanda Paulovich from the Fred Hutchinson Cancer Research Center.

May 17, 2007

MIRACLE MEDICINES: SEVEN LIFESAVING DRUGS AND THE PEOPLE WHO CREATED THEM

- GEN's Editor-in-Chief John Sterling interviews best selling author Robert Shook.

May 10, 2007

GLOBAL BIOINDUSTRY TRENDS IN 2007

- GEN's Editor-in-Chief John Sterling interviews Glen Giovannetti, Global Biotechnology Leader, Ernst & Young

May 3, 2007

HOW SCIENTISTS CAN MAKE A SUCCESSFUL TRANSITION FROM THE ACADEMIC WORLD TO A CAREER IN THE BIOPHARMACEUTICAL BUSINESS

- GEN's Editor-in-Chief John Sterling inteviews Dr. Gail Naughton, the Dean of the College of Business Administration at San Diego State University.

April 19, 2007

ADVANCED DRUG DELIVERY STRATEGIES

- GEN's Editor-in-Chief John Sterling interviews Felix Theeuwes, D.Sc., Chairman, Co-founder, and Chief Scientific Officer at DURECT Corporation.

April 12, 2007

HUMAN EMBRYONIC STEM CELL RESEARCH

GEN's Editor-in-Chief John Sterling interviews William Caldwell, CEO of Advanced Cell Technology.

April 5, 2007

DARWINIAN MEDICINE

- GEN's Editor-in-Chief John Sterling interviews Sharon Moalem, Ph.D., from the Mount Sinai School of Medicine in New York.

March 29, 2007

TEN YEARS AFTER DOLLY: WHERE ARE WE?

- GEN's Editor-in-Chief Interviews Ian Wilmut, Ph.D., Director, Scottish Centre for Regenerative Medicine, University of Edinburgh, and Editor-in-Chief of Cloning & Stem Cells.

March 22, 2007

RNAi TECHNOLOGY

- GEN's Editor-in-Chief John Sterling interviews Richard Jorgensen, Ph.D., from the University of Arizona

March 1, 2007

IMPROVING PHARMACEUTICAL PRODUCTIVITY

- GEN's Editor-in-Chief John Sterling talks with Charles T. Gombar, Ph.D. from Wyeth Research.